CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
1-Year Return
31.81%
This Quarter Return
+18.11%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$514M
AUM Growth
+$169M
(+49%)
Cap. Flow
+$116M
Cap. Flow
% of AUM
22.65%
Top 10 Holdings %
Top 10 Hldgs %
26.88%
Holding
503
New
57
Increased
239
Reduced
90
Closed
78
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$6.88M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$6.46M |
| 3 |
Gilead Sciences
GILD
|
+$6.38M |
| 4 |
Amgen
AMGN
|
+$6.24M |
| 5 |
Adobe
ADBE
|
+$5.19M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$5.18M |
| 2 |
Analog Devices
ADI
|
+$3.75M |
| 3 |
Amazon
AMZN
|
+$3.48M |
| 4 |
lululemon athletica
LULU
|
+$3.4M |
| 5 |
iQIYI
IQ
|
+$1.91M |
Sector Composition
| 1 | Technology | 34.39% |
| 2 | Healthcare | 30.05% |
| 3 | Consumer Discretionary | 17.55% |
| 4 | Communication Services | 6.11% |
| 5 | Consumer Staples | 4.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
ANI Pharmaceuticals
ANIP
$2.06B
| $131K | 0.03% |
2,367
+1,854
| +361% | +$102K |
|
|
ALPN
252
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $128K | 0.02% |
6,723
+5,454
| +430% | +$104K |
|
253
Pliant Therapeutics
PLRX
$107M
| $125K | 0.02% |
6,929
+5,400
| +353% | +$97.8K |
|
254
Zentalis Pharmaceuticals
ZNTL
$118M
| $124K | 0.02% |
8,188
+6,379
| +353% | +$96.6K |
|
255
Kura Oncology
KURA
$695M
| $124K | 0.02% |
8,590
+6,692
| +353% | +$96.2K |
|
256
DexCom
DXCM
$30.6B
| $123K | 0.02% |
994
-674
| -40% | -$83.6K |
|
|
VERV
257
DELISTED
Verve Therapeutics
VERV
| $123K | 0.02% |
8,815
+7,174
| +437% | +$100K |
|
258
Cintas
CTAS
$81.7B
| $121K | 0.02% |
804
-712
| -47% | -$107K |
|
259
Monster Beverage
MNST
$61.9B
| $119K | 0.02% |
2,071
-1,832
| -47% | -$106K |
|
260
Airbnb
ABNB
$75.8B
| $119K | 0.02% |
875
-722
| -45% | -$98.3K |
|
261
Innoviva
INVA
$1.29B
| $119K | 0.02% |
7,410
+5,736
| +343% | +$92K |
|
262
ADMA Biologics
ADMA
$3.92B
| $118K | 0.02% |
26,142
+20,378
| +354% | +$92.1K |
|
263
NXP Semiconductors
NXPI
$56.9B
| $118K | 0.02% |
510
-451
| -47% | -$104K |
|
264
Tango Therapeutics
TNGX
$758M
| $117K | 0.02% |
11,793
+9,530
| +421% | +$94.3K |
|
265
Collegium Pharmaceutical
COLL
$1.19B
| $116K | 0.02% |
3,776
+2,877
| +320% | +$88.6K |
|
266
Roper Technologies
ROP
$55.9B
| $116K | 0.02% |
+213
| New | +$116K |
|
267
Amylyx Pharmaceuticals
AMLX
$937M
| $115K | 0.02% |
7,815
+6,085
| +352% | +$89.6K |
|
268
Charter Communications
CHTR
$36B
| $115K | 0.02% |
295
-263
| -47% | -$102K |
|
269
MannKind Corp
MNKD
$1.71B
| $113K | 0.02% |
31,180
+24,288
| +352% | +$88.4K |
|
270
Cabaletta Bio
CABA
$150M
| $113K | 0.02% |
+4,962
| New | +$113K |
|
271
O'Reilly Automotive
ORLY
$90.3B
| $111K | 0.02% |
1,755
-1,620
| -48% | -$103K |
|
272
CureVac
CVAC
$1.21B
| $109K | 0.02% |
25,887
+20,149
| +351% | +$84.8K |
|
|
AUTL
273
Autolus Therapeutics
AUTL
$365M
| $105K | 0.02% |
+16,263
| New | +$105K |
|
274
PACCAR
PCAR
$51.6B
| $104K | 0.02% |
1,040
-908
| -47% | -$90.8K |
|
|
AMAM
275
DELISTED
Ambrx Biopharma, Inc. Common Stock
AMAM
| $104K | 0.02% |
+7,303
| New | +$104K |
|